A meta-analysis on the efficacy and tolerability of natalizumab in relapsing multiple sclerosis

INTRODUCTION: Natalizumab is a new humanized monoclonal antibody used in multiple sclerosis (MS). The aim of this meta-analysis was to evaluate the efficacy and tolerability of this drug in relapsing MS. PubMed, Scopus, Web of Science, and Cochrane Central Register of Controlled Trials were searched...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Nikfar, Shekoufeh, Rahimi, Roja, Rezaie, Ali, Abdollahi, Mohammad
Formato: Artigo
Idioma:Inglês
Publicado: Termedia Publishing House 2010
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3281346/
https://ncbi.nlm.nih.gov/pubmed/22371753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2010.13901
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares